LFACW Leapfrog details updated SPAC merger target evaluation progress in its latest quarterly earnings filing Amgen Inc AMGN Stem Cell Therapy Leadership Meets Balanced NearTerm Valuation Dynamics Fox Corporation FOX Options Volatility Signals Elevated Market Expectations Ahead of Fiscal Q3 2026 Earnings Release Intellectual Property Protection Trends for Creative Industry Assets Amid Generative AI Disruption Pyxis Oncology PYXS Management Strategy Pyxis Oncology posts 156 EPS beat no revenue TCRT Alaunos Therapeutics posts wider Q4 2023 loss than analyst estimates with shares slipping 039 percent in todays trading TSLA Tesla Q1 2026 EPS tops estimates by 78 percent stock gains 069 percent in todays trading What relative strength Brookfield RA Market Focus 20260501